If you are registering to attend the Biomed/Biotech Special Interest Group meeting on August 25, 2016 (Thursday) evening, please complete and submit the following information. The topic of this 178th discussion event of ours is "Overview of FDA's Expedited Program with a Case Study of Immunotherapy in Renal Cell Carcinoma."
Powered by Orchid Suites
Orchid ver. 4.7.6.